These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
690 related articles for article (PubMed ID: 20175837)
21. Connective tissue metabolism including cytokines in scleroderma. Smith EA Curr Opin Rheumatol; 1992 Dec; 4(6):869-77. PubMed ID: 1457283 [TBL] [Abstract][Full Text] [Related]
22. Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors. Ihn H; Yamane K; Kubo M; Tamaki K Arthritis Rheum; 2001 Feb; 44(2):474-80. PubMed ID: 11229480 [TBL] [Abstract][Full Text] [Related]
23. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts. Mori Y; Chen SJ; Varga J Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691 [TBL] [Abstract][Full Text] [Related]
24. Skin involvement in scleroderma--where histological and clinical scores meet. Verrecchia F; Laboureau J; Verola O; Roos N; Porcher R; Bruneval P; Ertault M; Tiev K; Michel L; Mauviel A; Farge D Rheumatology (Oxford); 2007 May; 46(5):833-41. PubMed ID: 17255134 [TBL] [Abstract][Full Text] [Related]
25. TGF beta--a role in systemic sclerosis? Cotton SA; Herrick AL; Jayson MI; Freemont AJ J Pathol; 1998 Jan; 184(1):4-6. PubMed ID: 9582519 [TBL] [Abstract][Full Text] [Related]
26. Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. Huber LC; Distler JH; Moritz F; Hemmatazad H; Hauser T; Michel BA; Gay RE; Matucci-Cerinic M; Gay S; Distler O; Jüngel A Arthritis Rheum; 2007 Aug; 56(8):2755-64. PubMed ID: 17665426 [TBL] [Abstract][Full Text] [Related]
27. CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts: demonstration of increased binding in systemic sclerosis fibroblasts. Saitta B; Gaidarova S; Cicchillitti L; Jimenez SA Arthritis Rheum; 2000 Oct; 43(10):2219-29. PubMed ID: 11037881 [TBL] [Abstract][Full Text] [Related]
28. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma. Pannu J; Gardner H; Shearstone JR; Smith E; Trojanowska M Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635 [TBL] [Abstract][Full Text] [Related]
29. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Wang Y; Fan PS; Kahaleh B Arthritis Rheum; 2006 Jul; 54(7):2271-9. PubMed ID: 16802366 [TBL] [Abstract][Full Text] [Related]
31. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis. Jelaska A; Korn JH Arthritis Rheum; 2000 Oct; 43(10):2230-9. PubMed ID: 11037882 [TBL] [Abstract][Full Text] [Related]
32. TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts. Honda N; Jinnin M; Kajihara I; Makino T; Makino K; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H J Immunol; 2012 Apr; 188(7):3323-31. PubMed ID: 22379029 [TBL] [Abstract][Full Text] [Related]
33. Activation of the activin A-ALK-Smad pathway in systemic sclerosis. Takagi K; Kawaguchi Y; Kawamoto M; Ota Y; Tochimoto A; Gono T; Katsumata Y; Takagi M; Hara M; Yamanaka H J Autoimmun; 2011 May; 36(3-4):181-8. PubMed ID: 21377836 [TBL] [Abstract][Full Text] [Related]
34. Src kinases in systemic sclerosis: central roles in fibroblast activation and in skin fibrosis. Skhirtladze C; Distler O; Dees C; Akhmetshina A; Busch N; Venalis P; Zwerina J; Spriewald B; Pileckyte M; Schett G; Distler JH Arthritis Rheum; 2008 May; 58(5):1475-84. PubMed ID: 18438865 [TBL] [Abstract][Full Text] [Related]
35. The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach. Corriveau MP; Boufaied I; Lessard J; Chabaud S; Senécal JL; Grodzicky T; Chartier S; Raymond Y; Moulin VJ J Pathol; 2009 Mar; 217(4):534-42. PubMed ID: 19086038 [TBL] [Abstract][Full Text] [Related]
36. [Transforming growth factor-beta and its receptors in scleroderma]. QIAN H; ZHENG M Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):415-21. PubMed ID: 19693982 [TBL] [Abstract][Full Text] [Related]
38. Autocrine TGF-beta signaling in the pathogenesis of systemic sclerosis. Ihn H J Dermatol Sci; 2008 Feb; 49(2):103-13. PubMed ID: 17628443 [TBL] [Abstract][Full Text] [Related]
39. Cytokines and human fibrosis. LeRoy EC; Trojanowska MI; Smith EA Eur Cytokine Netw; 1990; 1(4):215-9. PubMed ID: 1966552 [TBL] [Abstract][Full Text] [Related]
40. Collagen type I is not under autocrine control by transforming growth factor-beta 1 in normal and scleroderma fibroblasts. McWhirter A; Colosetti P; Rubin K; Miyazono K; Black C Lab Invest; 1994 Dec; 71(6):885-94. PubMed ID: 7807970 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]